Immuno-Oncology, Immune Therapy, Pd-1 In Melanoma - Omid Hamid Md

Immuno-Oncology, Immune Therapy, PD-1 in Melanoma - Omid Hamid MD

Novel Therapies for Metastatic Melanoma - Omid Hamid MD

Novel Therapies for Metastatic Melanoma - Melanoma Education Symposium, Omid Hamid MD

Dr. Hamid on Immune Therapy in Melanoma

Dr. Hamid on Immunotherapy Approaches in Melanoma

Dr. Hamid on Using Biomarkers for Immunotherapy in Melanoma

Key cellular therapy updates in melanoma

The future of immunotherapy in melanoma

Evolution of Immune Intelligent Immunotherapy

Institutional Perspectives in Cancer- Immunotherapy: Chaired by Omid Hamid, MD

The Angeles Clinic & Research Institute

Checkpoint Inhibitors in Metastatic Melanoma

The Future of Melanoma Therapy: how melanoma research has impacted cancer care

Cancer Immunotherapy - PD-1 and PD-L1

ASCO 2024: Advances in Melanoma and Related Cancers

Immunotherapy for Melanoma

Current and Emerging Immunotherapeutic Strategies in Melanoma

Targeted Oncology

Welcome & Introductions

Dr. Hamid on TMB as a Biomarker for Immunotherapy Response in Melanoma

Omid Hamid on Responses to Single Agent Immunotherapies Compared to Combination